Search research articles
Contact Us
Filters
Showing results (101-110 of 110) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 110 results.
Journal of Cellular Biochemistry. Supplement
|
January 1, 1992
Intermediate endpoint biomarkers for chemoprevention
G P Hemstreet, J Y Rao, R E Hurst, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
October 1, 1984
Immunoanatomic dissection of the human urinary tract by monoclonal antibodies
C Cordon-Cardo, N H Bander, Y Fradet, et al.
The Journal of Urology
|
September 1, 1996
Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. Canadian Urologic Oncology Group
S L Goldenberg, L H Klotz, J Srigley, et al.
Urology
|
March 1, 1996
A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia
M M Elhilali, E W Ramsey, J Barkin, et al.
Cytometry
|
January 1, 1991
Precision of DNA flow cytometry in inter-institutional analyses
L L Wheeless, J S Coon, C Cox, et al.
Urology
|
July 22, 1998
Liarozole--a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate. Liarozole Study Group
F J Debruyne, R Murray, Y Fradet, et al.
Urology
|
July 1, 1996
Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies
D G Bostwick, T M Wheeler, M Blute, et al.
British Journal of Cancer
|
November 22, 2012
Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling
E Xylinas, E K Cha, M Sun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 9, 2022
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up
A V Balar, D E Castellano, P Grivas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2019
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up
Y Fradet, J Bellmunt, D J Vaughn, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 110) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 110 results.
Journal of Cellular Biochemistry. Supplement
|
January 1, 1992
Intermediate endpoint biomarkers for chemoprevention
G P Hemstreet, J Y Rao, R E Hurst, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
October 1, 1984
Immunoanatomic dissection of the human urinary tract by monoclonal antibodies
C Cordon-Cardo, N H Bander, Y Fradet, et al.
The Journal of Urology
|
September 1, 1996
Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. Canadian Urologic Oncology Group
S L Goldenberg, L H Klotz, J Srigley, et al.
Urology
|
March 1, 1996
A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia
M M Elhilali, E W Ramsey, J Barkin, et al.
Cytometry
|
January 1, 1991
Precision of DNA flow cytometry in inter-institutional analyses
L L Wheeless, J S Coon, C Cox, et al.
Urology
|
July 22, 1998
Liarozole--a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate. Liarozole Study Group
F J Debruyne, R Murray, Y Fradet, et al.
Urology
|
July 1, 1996
Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies
D G Bostwick, T M Wheeler, M Blute, et al.
British Journal of Cancer
|
November 22, 2012
Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling
E Xylinas, E K Cha, M Sun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 9, 2022
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up
A V Balar, D E Castellano, P Grivas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2019
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up
Y Fradet, J Bellmunt, D J Vaughn, et al.
Page
of 11